Su; Shin-San Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Su; Shin-San Michael.The latest application filed is for "pyruvate kinase activators for use in therapy".

Company Profile

6.12.24

Su; Shin-San Michael - Boston MA
Su; Shin-San Michael - Newton MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyruvate Kinase Activators For Use In Therapy App 20210220351 - Su; Shin-San Michael ; et al.	2021-07-22
Pyruvate Kinase Activators For Use In Therapy App 20200289502 - Su; Shin-San Michael ; et al.	2020-09-17
Methods And Compositions For Cell-proliferation-related Disorders App 20200281501 - Dang; Lenny ; et al.	2020-09-10
Methods for diagnosing IDH-mutant cell proliferation disorders Grant 10,711,314 - Dang , et al.	2020-07-14
Pyruvate kinase activators for use in therapy Grant 10,632,114 - Su , et al.	2020-04-28
Methods and compositions for cell-proliferation-related disorders Grant 10,610,125 - Dang , et al.	2020-04-07
Method For Treating Cell Proliferation Related Disorders App 20190276894 - Dang; Leonard Luan C. ; et al.	2019-09-12
Pyruvate Kinase Activators For Use In Therapy App 20180338970 - Su; Shin-San Michael ; et al.	2018-11-29
Method for treating cell proliferation related disorders Grant 9,982,309 - Dang , et al. May 29, 2	2018-05-29
Pyruvate kinase activators for use in therapy Grant 9,980,961 - Su , et al. May 29, 2	2018-05-29
Methods And Compositions For Cell-proliferation-related Disorders App 20170325708 - Dang; Lenny ; et al.	2017-11-16
Pyruvate Kinase Activators For Use In Therapy App 20170290825 - Su; Shin-San Michael	2017-10-12
Pyruvate kinase activators for use in therapy Grant 9,682,080 - Su June 20, 2	2017-06-20
Methods And Compositions For Cell-proliferation-related Disorders App 20170044620 - Dang; Leonard Luan C. ; et al.	2017-02-16
Methods and compositions for cell-proliferation-related disorders Grant 9,434,979 - Su , et al. September 6, 2	2016-09-06
Pyruvate kinase activators for use in therapy Grant 9,404,081 - Su August 2, 2	2016-08-02
Pyruvate Kinase Activators For Use In Therapy App 20160106742 - Su; Shin-San Michael	2016-04-21
Methods And Compositions For Cell-proliferation-related Disorders App 20150240286 - Dang; Leonard Luan C ; et al.	2015-08-27
Method for diagnosing cell proliferation disorders having a neoactive mutation at residue 97 of isocitrate dehydrogenase 1 Grant 8,883,438 - Cantley , et al. November 11, 2	2014-11-11
Methods And Compositions For Cell-proliferation-related Disorders App 20140187435 - Dang; Leonard Luan C. ; et al.	2014-07-03
Pyruvate Kinase Activators For Use In Therapy App 20140155408 - Su; Shin-San Michael	2014-06-05
Methods And Compositions For Cell-proliferation-related Disorders App 20130316385 - Cantley; Lewis C. ; et al.	2013-11-28
Methods And Compositions For Cell-proliferation-related Disorders App 20130288284 - Dang; Leonard Luan C ; et al.	2013-10-31
Methods Of Identifying A Candidate Compound App 20130197106 - Fantin; Valeria ; et al.	2013-08-01
Methods And Compositons For Cell-proliferation-related Disorders App 20130183281 - Su; Shin-San Michael ; et al.	2013-07-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.